10XBeta Overview
- Year Founded
-
2010
- Status
-
Private
- Employees
-
39
- Latest Deal Type
-
Later Stage VC
- Investors
-
1
10XBeta General Information
Description
Developer of a venture studio designed to build and support medical technology startups operating in the healthcare innovation industry. The company offers venture development support, including product design, regulatory strategy, and commercialization expertise through an in-house team of product development specialists, enabling founders to de-risk ventures, accelerate product development, and bring medical technology products to market.
Contact Information
Website
www.10xbeta.comCorporate Office
- 63 Flushing Avenue, Building 303
- Suite 807, Brooklyn
- New York, NY 11205
- United States
Corporate Office
- 63 Flushing Avenue, Building 303
- Suite 807, Brooklyn
- New York, NY 11205
- United States
10XBeta Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Later Stage VC | 24-Mar-2023 | Completed | Generating Revenue |
10XBeta Comparisons
Industry
Financing
Details
10XBeta Competitors (1)
One of 10XBeta’s competitors is Redesign Health, a Venture Capital-Backed company based in New York, NY.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Redesign Health | Venture Capital-Backed | New York, NY |
10XBeta Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
10XBeta Patents
10XBeta Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-D1026866-S1 | Earpiece | Active | 09-Dec-2021 | ||
| AU-2022309011-A1 | Smart pill dispenser prescription treatment system | Pending | 06-Jul-2021 | ||
| CA-3225476-A1 | Smart pill dispenser prescription treatment system | Pending | 06-Jul-2021 | ||
| EP-4367681-A1 | Smart pill dispenser prescription treatment system | Pending | 06-Jul-2021 | ||
| EP-4367681-A4 | Smart pill dispenser prescription treatment system | Pending | 06-Jul-2021 | A61J7/0076 |
10XBeta Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
10XBeta Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Impact Assets | Impact Investing |
10XBeta Investments (3)
10XBeta’s most recent deal was a Seed Round with Validose for . The deal was made on 06-Jan-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Validose | 06-Jan-2025 | Seed Round | Drug Delivery | ||
| Australis Scientific | 09-Nov-2023 | Seed Round | Therapeutic Devices | ||
| Lynq | 07-Dec-2017 | Seed Round | Wireless Communications Equipment |
10XBeta FAQs
-
When was 10XBeta founded?
10XBeta was founded in 2010.
-
Where is 10XBeta headquartered?
10XBeta is headquartered in New York, NY.
-
What is the size of 10XBeta?
10XBeta has 39 total employees.
-
What industry is 10XBeta in?
10XBeta’s primary industry is Private Equity.
-
Is 10XBeta a private or public company?
10XBeta is a Private company.
-
What is 10XBeta’s current revenue?
The current revenue for 10XBeta is .
-
Who are 10XBeta’s investors?
Impact Assets has invested in 10XBeta.
-
Who are 10XBeta’s competitors?
Redesign Health is a competitor of 10XBeta.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
